Revolutionizing tuberculosis & pneumonia diagnostics
with breath sampling
The need
-
Global health threat: tuberculosis and pneumonia are the most deadly infectious diseases globally, causing around 4 million deaths annually¹
-
Challenge: rapid and accurate identification of the pathogen causing the infection is essential to guide treatment and reduce antibiotic overuse
-
Current limitations: shortcomings of existing sampling methods pose a major barrier to testing. Samples from the lower respiratory tract are hard to obtain, invasive, often unreliable, or prone to errors
-
Innovation needed: experts see breath sampling as a promising, non-invasive solution to transform tuberculosis and pneumonia diagnostics
Our solution: AveloMask - a breath aerosol collector
-
Our breath sampling kit contains a special mask and buffer tube, and works with existing molecular tests
-
Non-invasive and easy to use – anywhere, anytime
-
The filter inside the mask captures disease-causing viruses and bacteria from the lungs
-
After use, the filter can be quickly and easily transferred into the buffer tube for molecular testing
1. Collect
Wear for 30 minutes
2. Elute
Transfer to
lab tube with pathogen stabilizing buffer
3. Test and Treat
Diagnose & treat multiple diseases
The impact
-
Saving lives: better diagnosis for earlier and tailored antibiotic or antiviral treatment
-
Reducing healthcare costs: easy sample collection and diagnosis to keep patients out of the hospital and lower the annual costs of USD 52 billion in Europe alone²
-
Fighting antimicrobial resistance (AMR): AveloCollect works with existing respiratory multiplex tests which differentiate between viral and bacterial infections to reduce the more than 65% unnecessarily prescribed antibiotics in primary care³
-
Making every breath count: establish breath bioaerosols as a novel sample type for standard clinical diagnosis of respiratory infections
